MARTINI, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.366
EU - Europa 2.075
AS - Asia 913
SA - Sud America 127
AF - Africa 26
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.532
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.333
RU - Federazione Russa 705
PL - Polonia 452
SG - Singapore 242
HK - Hong Kong 206
SE - Svezia 203
CN - Cina 202
IE - Irlanda 167
IT - Italia 160
BR - Brasile 104
DE - Germania 99
KR - Corea 90
UA - Ucraina 83
FI - Finlandia 61
GB - Regno Unito 55
IN - India 51
VN - Vietnam 44
FR - Francia 33
CA - Canada 24
AU - Australia 23
JO - Giordania 20
TR - Turchia 17
BE - Belgio 15
NL - Olanda 11
AR - Argentina 10
CI - Costa d'Avorio 10
RO - Romania 8
ID - Indonesia 6
MX - Messico 6
VE - Venezuela 6
BD - Bangladesh 5
CH - Svizzera 5
CZ - Repubblica Ceca 5
EC - Ecuador 5
IQ - Iraq 5
PK - Pakistan 5
JP - Giappone 4
PH - Filippine 4
SC - Seychelles 4
ZA - Sudafrica 4
ES - Italia 3
LT - Lituania 3
AT - Austria 2
BG - Bulgaria 2
EU - Europa 2
HU - Ungheria 2
SA - Arabia Saudita 2
SN - Senegal 2
UZ - Uzbekistan 2
AM - Armenia 1
AZ - Azerbaigian 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LY - Libia 1
MA - Marocco 1
PE - Perù 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 6.532
Salva come PNG Salva come JPEG
Città #
Santa Clara 825
Warsaw 449
Ashburn 312
Fairfield 304
Chandler 253
Hong Kong 173
Dublin 167
Singapore 157
Jacksonville 132
Woodbridge 126
Seattle 116
Cambridge 115
Wilmington 99
Ann Arbor 94
Houston 93
Seoul 88
Beijing 69
Los Angeles 53
Buffalo 50
Princeton 42
Boston 41
Mumbai 36
Altamura 34
Dallas 32
Munich 31
Lawrence 29
Paris 27
Boardman 26
Hefei 23
Melbourne 23
New York 22
The Dalles 21
Falls Church 19
Shanghai 19
Phoenix 18
Ho Chi Minh City 16
Moscow 16
Brussels 15
Florence 12
Medford 12
Turku 12
San Diego 11
Abidjan 10
Council Bluffs 10
Dearborn 10
Izmir 10
Montreal 10
Rome 10
Hanoi 9
Kent 9
São Paulo 9
Denver 8
Dong Ket 8
Hillsboro 8
Tianjin 8
Toronto 8
London 7
Milan 7
Amsterdam 6
Brooklyn 6
Chicago 6
Frankfurt Am Main 6
Norwalk 6
Ankara 5
Helsinki 5
Kochi 5
San Francisco 5
Washington 5
Auburn Hills 4
Belo Horizonte 4
Edinburgh 4
Frankfurt am Main 4
Jakarta 4
Piscataway 4
Poplar 4
Verona 4
West Jordan 4
Yubileyny 4
Andover 3
Bari 3
Curitiba 3
Joinville 3
Olomouc 3
Quito 3
Stockholm 3
Tokyo 3
Zurich 3
Ascoli Piceno 2
Baghdad 2
Bologna 2
Bolzano 2
Brescia 2
Budapest 2
Campi Bisenzio 2
Caracas 2
Changsha 2
Chennai 2
Cuiabá 2
Dakar 2
Dhaka 2
Totale 4.501
Salva come PNG Salva come JPEG
Nome #
4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs 365
Design, synthesis and binding affinity of new nicotinic ligands 323
Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition-enhancers 293
DESIGN, SYNTHESIS AND PRELIMINARY PHARMACOLOGICAL EVALUATION OF RIGID ANALOGUES OF THE NICOTINIC AGONIST 1,1-DIMETHYL-4-PHENYLPIPERAZINIUM IODIDE (DMPP) 255
MOLECULAR MODULATION OF MUSCARINIC ANTAGONISTS. SYNTHESIS AND AFFINITY PROFILE OF 2,2-DIPHENYL-2-ETHYLTHIO-ACETIC ACID ESTERS DESIGNED TO PROBE THE BINDING SITE CAVITY 230
Design, synthesis and preliminary biological evaluation of new isoform-selective f-current blockers. 206
2-PYRROLIDINONE MOIETY IS NOT CRITICAL FOR THE COGNITION ENHANCING ACTIVITY OF PIRACETAM-LIKE DRUGS 193
Design, synthesis and preliminary biological evaluation of zatebradine analogues as potential blockers of the hyperpolarization-activated current 190
Design, Synthesis, and Preliminary Pharmacological Evaluation of New Quinoline Derivatives as Nicotinic Ligands 187
Central Nicotinic receptors: structure, function, ligands, and therapeutic potential 182
Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist. 181
Design, synthesis and nootropic activity of new analogues of sunifiram and sapunifiram, two potent cognition-enhancers. 177
Antagonisti muscarinici a struttura 1,3-ossatiolano-2-pirrolidinica 177
SYNTHESIS, AFFINITY PROFILE AND FUNCTIONAL ACTIVITY OF MUSCARINIC ANTAGONISTS WITH A 1-METHYL-2-(2,2-ALKYLARYL-1,3-OXATHIOLAN-5-YL)PYRROLIDINE STRUCTURE 171
COGNITION-ENHANCING DRUGS IN MILD COGNITIVE IMPAIRMENT (MCI) AND ALZHEIMER'S DISEASE (AD): AN UPDATE[1] 170
Design of novel nicotinic ligands through 3D database searching 165
Design, synthesis and preliminary pharmacological evaluation of new piperidine and piperazine derivatives as cognition-enhancers 159
Design, synthesis and pharmacological evaluation of some frozen-analogues of DMPP 158
Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators. 155
Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators 149
[35S]GTPgammaS binding studies of amphiphilic drugs-activated Gi proteins: A caveat 138
Enantioselective synthesis and preliminary pharmacological evaluation of the enantiomers of unifiram (DM232), a potent cognition-enhancing agent 135
Synthesis and Biological Evaluation of 3,7-Diazabicyclo[4.3.0]2 nonan-8-ones as Potential Nootropic and Analgesic Drugs 133
Structure-activity relationship studies on unifiram (DM232) and sunifiram (DM235), two novel and potent cognition enhancing drugs 132
Synthesis, Affinity Profile and Functional Activity of Potent Chiral Muscarinic Antagonists with a Pyrrolidinylfuran Structure 129
Influence of ring size on the cognition-enhancing activity of DM235 and MN19, two potent nootropic drugs 127
Modulazione molecolare di antagonisti muscarinici. Sintesi e valutazione farmacologica preliminare di esteri amminoalchil piperazinici e piperidinici dell'acido 2,2-difenil-2-etiltioacetico 127
Design, synthesis and preliminary pharmacological evaluation of 1,4-diaminobenzenes and 1,4-diaminocyclohexanes as cognition modulators 122
Metodo per rimuovere un gruppo protettivo di un composto tetrazolico N-protetto 121
DM232 and DM235, two potent cognition-enhancers, increase NO levels in rat adipocytes 119
Highly chiral muscarinic ligands: synthesis and affinity of diastereomeric and enantiomeric isomers of 1-methyl-2-(2-methyl-1,3-oxathiolane-5-yl)pyrrolidine 3-sulfoxides and their methyl iodides 117
synthesis, chiral HPLC separation and pharmacological characterization of muscarinic furan derivatives 114
Rigid Analogs of DMPP As Probes For The Nicotinic Receptors 114
Design, synthesis and pharmacological evaluation of novel analogues of the two nootropics unifiram (DM232) and sunifiram (DM235) 110
Influence of ring size on the cognition-enhancing activity of DM235 and MN19, two potent nootropic drugs 110
Sintesi e valutazione farmacologica di derivati furanici e tetraidrofuranici a potenziale azione muscarinica 109
Synthesis and pharmacological evaluation of new nicotinic ligands carrying a quinoline nucleus 98
Synthesis and pharmacological characterization of diastereomeric and enantiomeric isomers of 1-methyl-2-(2-methyl-1,3-oxathiolane-5-yl)pyrrolidine 3-sulfoxides and their methyl iodides 94
Intermediate compounds for the preparation of angiotensin II antagonists 93
Sintesi chirale e valutazione farmacologica preliminare degli enantiomeri di DM232 e MC68, due azabiciclononanoni modulatori dei processi cognitivi 88
Molecular simplification of DM232 and DM235, two new potent cognition enhancers 85
Progettazione, sintesi e valutazione farmacologica preliminare di analoghi strutturali di Sunifiram e Sapunifiram, due potemti agenti nootropi 76
Totale 6.577
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.759
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.759
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021292 0 0 0 0 0 63 17 49 34 64 23 42
2021/2022328 16 46 30 5 9 18 23 11 10 13 73 74
2022/2023857 70 144 30 94 54 161 109 65 90 5 30 5
2023/2024308 11 30 46 13 17 57 9 85 5 6 10 19
2024/20252.042 55 212 126 280 649 348 13 124 54 57 64 60
2025/20261.031 245 280 134 107 240 25 0 0 0 0 0 0
Totale 6.577